SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-045979
Filing Date
2024-11-07
Accepted
2024-11-07 07:16:53
Documents
93
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q akba-20240930.htm   iXBRL 10-Q 2085133
2 EX-10.4 exhibit104amendment1-avero.htm EX-10.4 13994
3 EX-10.5 exhibit105akebiastaamendme.htm EX-10.5 24325
4 EX-31.1 exhibit311-q32024.htm EX-31.1 10975
5 EX-31.2 exhibit312-q32024.htm EX-31.2 11035
6 EX-32.1 exhibit321-q32024.htm EX-32.1 7540
12 GRAPHIC akba-20240930_g1.gif GRAPHIC 3995
  Complete submission text file 0001628280-24-045979.txt   9511033

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT akba-20240930.xsd EX-101.SCH 80518
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT akba-20240930_cal.xml EX-101.CAL 83535
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT akba-20240930_def.xml EX-101.DEF 346654
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT akba-20240930_lab.xml EX-101.LAB 847338
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT akba-20240930_pre.xml EX-101.PRE 588091
96 EXTRACTED XBRL INSTANCE DOCUMENT akba-20240930_htm.xml XML 1156709
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36352 | Film No.: 241433152
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)